Data Solutions for Imaging Biomarker Discovery and Clinical Endpoint Validation

Time: 12:00 pm
day: Day Two Track B - Morning


  • Dearth of meaningful endpoints remains hurdle in ophthalmic gene therapy trials
  • Biomarkers and endpoints are not born, they are discovered and validated
  • Clinical standards of care are insufficient, and must be supported with emerging imaging modalities and analyses